Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

RVTY

Revvity (RVTY)

Revvity Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:RVTY
FechaHoraFuenteTítuloSímboloCompañía
02/12/202409:55Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:RVTYRevvity Inc
20/11/202407:00Business WireRevvity Broadens Relationship with Genomics England to Advance Genomics in the UKNYSE:RVTYRevvity Inc
19/11/202407:00Business WireScale Biosciences and Revvity’s BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single CellsNYSE:RVTYRevvity Inc
19/11/202407:00Business WireRevvity to Present at 7th Annual Evercore ISI HealthCONx ConferenceNYSE:RVTYRevvity Inc
18/11/202407:00Business WireRevvity to Host Investor Day and Updates Organizational Structure to Reflect Recent TransformationNYSE:RVTYRevvity Inc
14/11/202415:30Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NYSE:RVTYRevvity Inc
14/11/202412:22Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNYSE:RVTYRevvity Inc
06/11/202415:13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:RVTYRevvity Inc
04/11/202405:11Edgar (US Regulatory)Form 8-K - Current reportNYSE:RVTYRevvity Inc
04/11/202405:00Business WireRevvity Announces Financial Results for the Third Quarter of 2024NYSE:RVTYRevvity Inc
24/10/202415:05Business WireRevvity Board Declares Quarterly DividendNYSE:RVTYRevvity Inc
22/10/202408:00Business WireRevvity Introduces Transcribe AI: Revolutionizing Data Entry in Clinical LaboratoriesNYSE:RVTYRevvity Inc
22/10/202407:00Business WireRevvity Highlights its Strong Progress on Sustainability and Workplace Culture in 2024 Impact ReportNYSE:RVTYRevvity Inc
10/10/202415:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:RVTYRevvity Inc
07/10/202416:21Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NYSE:RVTYRevvity Inc
07/10/202407:00Business WireRevvity To Hold Earnings Call on Monday, November 4, 2024NYSE:RVTYRevvity Inc
02/10/202407:00Business WireRevvity's EUROIMMUN Launches Solution for Specific Typing of Alzheimer's Disease Associated APOE GeneNYSE:RVTYRevvity Inc
21/08/202407:00Business WireRevvity to Present at Upcoming Investor ConferencesNYSE:RVTYRevvity Inc
29/07/202405:00Business WireRevvity Announces Financial Results for the Second Quarter of 2024NYSE:RVTYRevvity Inc
09/07/202407:00Business WireRevvity To Hold Earnings Call on Monday, July 29, 2024NYSE:RVTYRevvity Inc
20/06/202407:00GlobeNewswire Inc.Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing ResearchNYSE:RVTYRevvity Inc
31/05/202407:00Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:RVTYRevvity Inc
28/05/202407:00Business WireRevvity to Present at Goldman Sachs Global Healthcare ConferenceNYSE:RVTYRevvity Inc
29/04/202405:00Business WireRevvity Announces Financial Results for the First Quarter of 2024NYSE:RVTYRevvity Inc
25/04/202407:00Business WireRevvity to Present at BofA Securities 2024 Health Care ConferenceNYSE:RVTYRevvity Inc
24/04/202405:00Business WireRevvity Unveils a New Era of Automated Tuberculosis TestingNYSE:RVTYRevvity Inc
15/04/202405:00Business WireRevvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract PartnersNYSE:RVTYRevvity Inc
04/04/202407:00Business WireRevvity To Hold Earnings Call on Monday, April 29, 2024NYSE:RVTYRevvity Inc
02/04/202405:00Business WirePreliminary Injunction Granted to Enforce Revvity’s Rights and Cloud Software Group’s Obligations Related to Spotfire SoftwareNYSE:RVTYRevvity Inc
20/03/202416:00Business WireRevvity Files Complaint and Seeks Injunctive Relief Against Cloud Software GroupNYSE:RVTYRevvity Inc
 Showing the most relevant articles for your search:NYSE:RVTY